International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-4 doi: 10.5281/zenodo.13221222
Case Report
Case Report: Management of Hypoalbuminemia with A Semi-Elemental Egg White Derived Nutrition Formulation
Published
Aug. 5, 2024
Abstract

Hypoalbuminemia is generally defined as a serum albumin concentration ≤3.0 g/dl. Hypoalbuminemia is linked to poor outcomes, including an increase in complications, regardless of the underlying processes, also reduced short-term and long-term survival in critical patients. Malnourished patients have high protein needs, and research shows that providing them enough protein can lower mortality and enhance quality of life. Egg whites contain all the essential amino acids required, and it has many beneficial effects on the body. Peptides generated from egg whites maintain the nutritional value of egg whites and are easily absorbed in the body. We reported three cases studies to demonstrate the effectiveness of oral administration of egg white passed formulation in hospitalized patients with hypoalbuminemia and observed that, administration of High Protein Albumin Formula (Albuwise) is safe and effective in improving serum albumin level among hospitalized patient with low serum albumin levels

Recommended Articles
Loading Image...
Volume-5, Issue-4
Citations
854 Views
387 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved